-
November 13: The Week in Cancer NewsA survey indicates that the pandemic is reducing cancer patients' willingness to enroll in cancer clinical trials, and a study find that indoor tanning increases risk of developing melanoma multiple times.
by Kate Yandell
-
November 6: The Week in Cancer NewsCancer survivors who use the internet for health-related reasons are more likely to be dissatisfied with their care, and liquid biopsy could misidentify which prostate cancer patients could benefit from targeted therapy.
by Kate Yandell
-
October 30: The Week in Cancer NewsThe U.S. Preventive Services Task Force releases draft guidance suggesting lowering the age at which people should begin routine colorectal cancer screening, and an ovarian cancer patient considers what clinical trials owe participants.
by Kate Yandell
-
October 23: The Week in Cancer NewsA newly discovered set of salivary glands could have implications for protecting head and neck cancer patients from radiation side effects, and younger melanoma patients respond better to a targeted therapy than older patients.
by Kate Yandell
-
October 16: The Week in Cancer NewsA study finds that some commercially insured patients getting screening colonoscopies receive a bill for out-of-network services, and a machine learning algorithm helps nudge oncology clinicians to talk about prognosis and the end of life.
by Kate Yandell
-
October 9: The Week in Cancer NewsA study finds that more than half of cancer patients participate in clinical trials when asked, and an annual survey sheds light on cancer patients' experience of the coronavirus pandemic.
by Kate Yandell
-
October 2: The Week in Cancer NewsA study finds that human papillomavirus vaccination reduces the rate of cervical cancer, and pediatric cancer researchers identify tradeoffs between reducing recurrence risk and minimizing long-term effects of treatment.
by Kate Yandell
-
September 25: The Week in Cancer NewsA trial shows that a form of targeted chemotherapy lengthens life for people with metastatic, triple-negative breast cancer, and researchers release more data on targeting KRAS-mutated lung cancer.
by Kate Yandell
-
Cancer Diagnoses and Research ContinueAmid the ongoing pandemic, Cancer Today continues to cover cancer research and treatment while also reporting on the many ways COVID-19 has impacted people with cancer.
by Kevin McLaughlin
-
September 18: The Week in Cancer NewsA report finds that more progress is needed to reduce cancer health disparities, and a study indicates that drinking large amounts of coffee may slightly lengthen survival for people with advanced or metastatic colorectal cancer.
by Kate Yandell
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
